Submit data
Ask about dataset readiness, metadata, files, packages, or repository links.
Open-source ecosystem for in vitro and microphysiological systemsContact
Contact the team about data submission, dataset discovery, open-source resources, review workflows, governance, training, or institutional participation.
Contact pathway
Use this page to route questions about contribution, search, access, tools, review, or participation. A short message with your role and interest area is enough to start.
Email the TeamCommon reasons to contact us
Ask about dataset readiness, metadata, files, packages, or repository links.
Ask about catalog search, download, access, or reuse expectations.
Ask about templates, tools, validation resources, documentation, or examples.
Ask about curator review, participation, institutional use, or sustainability.
Quick links
Use the links below to start searching, prepare a submission, or sign in.
Standards and manufacturing partners
Connect with the organizations advancing consensus standards, validation, and regenerative manufacturing across the PhysioVerse ecosystem.
The Microphysiological and Organoid Systems Standards Development Organization (MOSSDO) is a federally funded multi-stakeholder initiative focused specifically on establishing consensus-based standards for organoids, microphysiological systems (MPS), and body-on-a-chip technologies. MOSSDO develops frameworks for reproducibility, validation, and interoperability, enabling these platforms to be more reliably adopted across research, regulatory, and translational settings. In coordination with enabling ecosystem efforts such as PhysioVerse, MOSSDO provides the standards foundation that supports data integration, comparability, and broader field-wide adoption.
The Regenerative Manufacturing Innovation Consortium (RegMIC), founded in 2014, is a national initiative that brings together stakeholders from industry, academia, and government to advance the manufacturing, scale-up, and commercialization of regenerative technologies. Through cross-sector collaboration, RegMIC addresses key challenges in translation, including process development, regulatory alignment, and the establishment of best practices across cell, tissue, and advanced in vitro systems.